EpiMedTech Global
PrivateCompany Overview
EpiMedTech Global is a biotechnology company that specializes in epigenetics-based early disease detection and personalized health solutions through DNA methylation analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
clinical epigeneticsDNA methylation analysisearly cancer detectionbiological age testepigenetic clocklongevity testingpersonalized medicinenon-invasive diagnosticsbioinformaticsnext-generation sequencingNGSdirect-to-consumer healthD2C healthbiohackingliquid biopsy
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EpiMedTech Global Comparables
Compare EpiMedTech Global with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epimorphy, LLC | 81% | |
| Infinite Epigenetics | 81% | |
| TruDiagnostic | 79% | |
EpiMedTech Global Funding Rounds
Historical fundraising activity
EpiMedTech Global Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EpiMedTech Global's valuation, stock price, and market status.
See something wrong or outdated?